Citation Tools
PDFClinical/translational cancer immunotherapy
Original research
Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival